Acute portal vein thrombosis secondary to COVID-19: a case report

Abstract

<jats:title>Abstract</jats:title> <jats:p><jats:bold>Introduction:</jats:bold> COVID-19 pneumonia exhibits several extra-pulmonary complications.<jats:bold>Case presentation: </jats:bold>We described a 23-year old male with coronavirus pneumonia and portal vein thrombosis.<jats:bold>Conclusion: </jats:bold>Clinicians should always consider thrombosis and other hypercoagulable diseases in patients with COVID-19.</jats:p>

A fatal case of extensive gastrointestinal necrosis due to portal and mesenteric vein thrombosis in the post-acute phase of COVID-19

“…PVT was reported as a rare complication among COVID-19 [1,2] and, similar with other thrombotic events, was developed within 2 weeks from admission in most previous case reports [6][7][8]. However, limited in COVID-19 patients with ischemic gastrointestinal complications, portal or mesenteric vein thrombosis was found in approximately one-fifth of patients [9].…”

Acute Portal Vein Thrombosis during COVID-19 Convalescent Phase

“…PVT with COVID-19 represents a less common association, but one that requires further review and acknowledgement. Our case represents the ninth such reported COVID-19associated PVT [2][3][4][5][6][7][8][9].…”

“…Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome corovirus-2 (SARS-CoV-2) has been associated with hypercoagulability, with recent literature identifying arterial and venous thromboembolism as potential complications [1]. ere have also been several case studies that describe portal vein thrombosis (PVT) complicating COVID-19, most of which occurred at the time of acute respiratory illness [2][3][4][5][6][7][8][9][10][11]. We present a case of acute portal vein thrombosis in the convalescent phase as identified by the presence of SARS-CoV-2 IgG antibodies.…”

Coagulation disorders and vascular diseases of the liver in patients with COVID-19

“…All case reports and one case series reporting thrombotic events in the liver in the context of COVID-19 are summarized in Table 1 [9][10][11][12][13][14][15][16][17][18][19].…”